BWELL FIRST AID ANTIBIOTIC- tetracycline hydrochloride spray 
Viaderma II, Inc

----------

BWell First Aid Antibiotic

Drug Facts

Active Ingredient (in each gram)

Tetracycline-HCl 30mg

Purpose

First Aid/Antibiotic

Indications

First aid to help prevent the risk of skin infection in minor cuts, scrapes, or burns.

Warnings

For external use only. May be harmful if swallowed.

Allergy Alert 

Do not use if allergic to any ingredient listed on this label.


Do not use

  • in eyes
  • over large areas of the body
  • longer than 1 week unless directed by doctor

Ask a doctor before use if you have

  • deep or puncture wounds
  • animal bites
  • serious trauma

Stop use and ask a doctor if

condition persists or gets worse

Keep out of reach of children.

If swallowed, get medical help or contact a Poison control Center right away.

Directions

■ clean the affected area ■ apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily ■ may be covered with a sterile bandage

Stop use if product is misused

■ this product is an OTC antibiotic for human use ■ contains no alcohol, no animal ingredients ■ blended for typical skin color ■ may stain cloth ■ no claims regarding stem cell healing are implied for this product



Other Information

■ store in cool dark place

Inactive Ingredients

acetic acid, ascorbic acid, chlorhexidine gluconate, cholecalciferol, dimethyl sulfoxide, dipropylene glycol, glucono delta lactone, glycerin, histidine, hydroxethyl-cellulose, magnesium stearate, sodium hydroxide, sorbic acid, stearic acid, water

Package Labeling:

BottleBottle2

BWELL FIRST AID ANTIBIOTIC 
tetracycline hydrochloride spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69006-012
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TETRACYCLINE HYDROCHLORIDE (UNII: P6R62377KV) (TETRACYCLINE - UNII:F8VB5M810T) TETRACYCLINE HYDROCHLORIDE30 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ACETIC ACID (UNII: Q40Q9N063P)  
ASCORBIC ACID (UNII: PQ6CK8PD0R)  
CHLORHEXIDINE GLUCONATE (UNII: MOR84MUD8E)  
CHOLECALCIFEROL (UNII: 1C6V77QF41)  
DIMETHYL SULFOXIDE (UNII: YOW8V9698H)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
GLUCONOLACTONE (UNII: WQ29KQ9POT)  
GLYCERIN (UNII: PDC6A3C0OX)  
HISTIDINE (UNII: 4QD397987E)  
HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SORBIC ACID (UNII: X045WJ989B)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69006-012-011 in 1 BOX05/01/2020
155 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00405/01/2020
Labeler - Viaderma II, Inc (079387584)

Revised: 11/2023
Document Id: 0b5a0b1d-6e4b-58f0-e063-6294a90af9fc
Set id: ab9579a0-aced-ecdd-e053-2a95a90afd37
Version: 3
Effective Time: 20231130
 
Viaderma II, Inc